scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
BURLINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Month: May 2022
Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
Collegium to Participate in H.C. Wainwright Global Investment Conference
STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Excision BioTherapeutics to Present Preclinical and Bioinformatic Data Showing Robust and Specific Editing of HIV Proviral DNA with EBT-101 at the ASGCT 25th Annual Meeting
EBT-101 achieves HIV excision without detectable off-target effects Poster presentation to take place today from…
BrightInsight Adds Biopharma Technology and Digital Health Expert, Karl Hick, to Advisory Council
Former Chief Digital and Information Officer at Takeda Brings 25 Years of Pharma, Technology and…
Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference
PHILADELPHIA, May 17, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
Jasper Therapeutics Announces Treatment of First Patient in Study of JSP191 Conditioning in Patients with Fanconi Anemia
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
LONDON and REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Finch Therapeutics to Present at the H.C. Wainwright Global Investment Conference
SOMERVILLE, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in…
Entasis Therapeutics Presents Data Highlights from Phase 3 ATTACK Trial at 2022 American Thoracic Society Annual Conference
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a…
Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
Nephros Receives FDA 510(k) Clearance for HDF Assist Module
The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy…
Avalo to Present at the H.C. Wainwright Global Life Sciences Conference
WAYNE, Pa. and ROCKVILLE, Md., May 17, 2022 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
InflaRx to Present at the H.C. Wainwright Global Investment Conference
JENA, Germany, May 17, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
CHARLOTTESVILLE, Va., May 17, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or…
Arbutus to Present at H.C. Wainwright Global Investment Conference
WARMINSTER, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference
BOSTON, May 17, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
BridgeBio Pharma to Participate in May Investor Events
PALO ALTO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…